Squawk on the Street China Retaliates Against U.S. Tariffs, Palantir Soars, Merck Tumbles 02/04/25
Feb 4, 2025
The podcast dives into China's tactical trade retaliation against new U.S. tariffs, revealing strategic implications for companies like PVH and Illumina. Palantir's soaring stock fueled by AI demand and CEO insights hints at transformative growth. Meanwhile, Merck faces challenges as vaccine sales in China stall, impacting its stock performance. Consumer behavior shifts are highlighted with Pepsi's struggles amidst rising health consciousness. Plus, humorous takes on surging food prices and outlandish dining surcharges add a light-hearted touch.
AI Snips
Chapters
Transcript
Episode notes
China's Retaliatory Tariffs
- China retaliated with tariffs on U.S. goods, but they seem designed to avoid escalation.
- The targeted goods, like coal and natural gas, are in high demand elsewhere, minimizing the impact.
Palantir's AI-Driven Growth
- Palantir's strong outlook is driven by AI demand, and its CEO, Alex Karp, sees a windfall from government cost-cutting.
- Jim Cramer praises Palantir's "ontology" approach, bridging data and insights, and predicts significant growth.
Karp on Musk and DoD
- Alex Karp, Palantir's CEO, discussed Elon Musk's efforts and the Department of Defense on the earnings call.
- Karp welcomes disruption, expecting Palantir to benefit from exposing inefficiencies and winning in the changing landscape.